EROSION III: A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency
The aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes in patients with ST-segment elevation myocardial infarctio...
Saved in:
Published in | JACC. Cardiovascular interventions Vol. 15; no. 8; p. 846 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
25.04.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 1876-7605 1876-7605 |
DOI | 10.1016/j.jcin.2022.01.298 |
Cover
Loading…
Abstract | The aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) with early infarct artery patency.
Angiography is limited in assessing the underlying pathophysiological mechanisms of the culprit lesion.
EROSION III (Optical Coherence Tomography-Guided Reperfusion in ST-Segment Elevation Myocardial Infarction With Early Infarct Artery Patency) is an open-label, prospective, multicenter, randomized, controlled study approved by the ethics committees of participating centers. Patients with STEMI who had angiographic diameter stenosis ≤ 70% and TIMI (Thrombolysis In Myocardial Infarction) flow grade 3 at presentation or after antegrade blood flow restoration were recruited and randomized to either OCT guidance or angiographic guidance. The primary efficacy endpoint was the rate of stent implantation.
Among 246 randomized patients, 226 (91.9%) constituted the per protocol set (112 with OCT guidance and 114 with angiographic guidance). The median diameter stenosis was 54.0% (IQR: 48.0%-61.0%) in the OCT guidance group and 53.5% (IQR: 43.8%-64.0%) in the angiographic guidance group (P = 0.57) before randomization. Stent implantation was performed in 49 of 112 patients (43.8%) in the OCT group and 67 of 114 patients (58.8%) in the angiographic group (P = 0.024), demonstrating a 15% reduction in stent implantation with OCT guidance. In patients treated with stent implantation, OCT guidance was associated with a favorable result with lower residual angiographic diameter stenosis (8.7% ± 3.7% vs 11.8% ± 4.6% in the angiographic guidance group; P < 0.001). Two patients (1 cardiac death, 1 stable angina) met the primary safety endpoint in the OCT guidance group, as did 3 patients (3 cardiac deaths) in the angiographic guidance group (1.8% vs 2.6%; P = 0.67). Reinfarction was not observed in either group. At 1 year, the rates of predefined cardiocerebrovascular events were comparable between the groups (11.6% after OCT guidance vs 9.6% after angiographic guidance; P = 0.66).
In patients with STEMI with early infarct artery patency, OCT guidance compared with angiographic guidance of reperfusion was associated with less stent implantation during primary percutaneous coronary intervention. These favorable results indicate the value of OCT imaging in optimizing the reperfusion strategy of patients with STEMI. (EROSION III: OCT- vs Angio-Based Reperfusion Strategy for STEMI; NCT03571269). |
---|---|
AbstractList | The aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) with early infarct artery patency.OBJECTIVESThe aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) with early infarct artery patency.Angiography is limited in assessing the underlying pathophysiological mechanisms of the culprit lesion.BACKGROUNDAngiography is limited in assessing the underlying pathophysiological mechanisms of the culprit lesion.EROSION III (Optical Coherence Tomography-Guided Reperfusion in ST-Segment Elevation Myocardial Infarction With Early Infarct Artery Patency) is an open-label, prospective, multicenter, randomized, controlled study approved by the ethics committees of participating centers. Patients with STEMI who had angiographic diameter stenosis ≤ 70% and TIMI (Thrombolysis In Myocardial Infarction) flow grade 3 at presentation or after antegrade blood flow restoration were recruited and randomized to either OCT guidance or angiographic guidance. The primary efficacy endpoint was the rate of stent implantation.METHODSEROSION III (Optical Coherence Tomography-Guided Reperfusion in ST-Segment Elevation Myocardial Infarction With Early Infarct Artery Patency) is an open-label, prospective, multicenter, randomized, controlled study approved by the ethics committees of participating centers. Patients with STEMI who had angiographic diameter stenosis ≤ 70% and TIMI (Thrombolysis In Myocardial Infarction) flow grade 3 at presentation or after antegrade blood flow restoration were recruited and randomized to either OCT guidance or angiographic guidance. The primary efficacy endpoint was the rate of stent implantation.Among 246 randomized patients, 226 (91.9%) constituted the per protocol set (112 with OCT guidance and 114 with angiographic guidance). The median diameter stenosis was 54.0% (IQR: 48.0%-61.0%) in the OCT guidance group and 53.5% (IQR: 43.8%-64.0%) in the angiographic guidance group (P = 0.57) before randomization. Stent implantation was performed in 49 of 112 patients (43.8%) in the OCT group and 67 of 114 patients (58.8%) in the angiographic group (P = 0.024), demonstrating a 15% reduction in stent implantation with OCT guidance. In patients treated with stent implantation, OCT guidance was associated with a favorable result with lower residual angiographic diameter stenosis (8.7% ± 3.7% vs 11.8% ± 4.6% in the angiographic guidance group; P < 0.001). Two patients (1 cardiac death, 1 stable angina) met the primary safety endpoint in the OCT guidance group, as did 3 patients (3 cardiac deaths) in the angiographic guidance group (1.8% vs 2.6%; P = 0.67). Reinfarction was not observed in either group. At 1 year, the rates of predefined cardiocerebrovascular events were comparable between the groups (11.6% after OCT guidance vs 9.6% after angiographic guidance; P = 0.66).RESULTSAmong 246 randomized patients, 226 (91.9%) constituted the per protocol set (112 with OCT guidance and 114 with angiographic guidance). The median diameter stenosis was 54.0% (IQR: 48.0%-61.0%) in the OCT guidance group and 53.5% (IQR: 43.8%-64.0%) in the angiographic guidance group (P = 0.57) before randomization. Stent implantation was performed in 49 of 112 patients (43.8%) in the OCT group and 67 of 114 patients (58.8%) in the angiographic group (P = 0.024), demonstrating a 15% reduction in stent implantation with OCT guidance. In patients treated with stent implantation, OCT guidance was associated with a favorable result with lower residual angiographic diameter stenosis (8.7% ± 3.7% vs 11.8% ± 4.6% in the angiographic guidance group; P < 0.001). Two patients (1 cardiac death, 1 stable angina) met the primary safety endpoint in the OCT guidance group, as did 3 patients (3 cardiac deaths) in the angiographic guidance group (1.8% vs 2.6%; P = 0.67). Reinfarction was not observed in either group. At 1 year, the rates of predefined cardiocerebrovascular events were comparable between the groups (11.6% after OCT guidance vs 9.6% after angiographic guidance; P = 0.66).In patients with STEMI with early infarct artery patency, OCT guidance compared with angiographic guidance of reperfusion was associated with less stent implantation during primary percutaneous coronary intervention. These favorable results indicate the value of OCT imaging in optimizing the reperfusion strategy of patients with STEMI. (EROSION III: OCT- vs Angio-Based Reperfusion Strategy for STEMI; NCT03571269).CONCLUSIONSIn patients with STEMI with early infarct artery patency, OCT guidance compared with angiographic guidance of reperfusion was associated with less stent implantation during primary percutaneous coronary intervention. These favorable results indicate the value of OCT imaging in optimizing the reperfusion strategy of patients with STEMI. (EROSION III: OCT- vs Angio-Based Reperfusion Strategy for STEMI; NCT03571269). The aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) with early infarct artery patency. Angiography is limited in assessing the underlying pathophysiological mechanisms of the culprit lesion. EROSION III (Optical Coherence Tomography-Guided Reperfusion in ST-Segment Elevation Myocardial Infarction With Early Infarct Artery Patency) is an open-label, prospective, multicenter, randomized, controlled study approved by the ethics committees of participating centers. Patients with STEMI who had angiographic diameter stenosis ≤ 70% and TIMI (Thrombolysis In Myocardial Infarction) flow grade 3 at presentation or after antegrade blood flow restoration were recruited and randomized to either OCT guidance or angiographic guidance. The primary efficacy endpoint was the rate of stent implantation. Among 246 randomized patients, 226 (91.9%) constituted the per protocol set (112 with OCT guidance and 114 with angiographic guidance). The median diameter stenosis was 54.0% (IQR: 48.0%-61.0%) in the OCT guidance group and 53.5% (IQR: 43.8%-64.0%) in the angiographic guidance group (P = 0.57) before randomization. Stent implantation was performed in 49 of 112 patients (43.8%) in the OCT group and 67 of 114 patients (58.8%) in the angiographic group (P = 0.024), demonstrating a 15% reduction in stent implantation with OCT guidance. In patients treated with stent implantation, OCT guidance was associated with a favorable result with lower residual angiographic diameter stenosis (8.7% ± 3.7% vs 11.8% ± 4.6% in the angiographic guidance group; P < 0.001). Two patients (1 cardiac death, 1 stable angina) met the primary safety endpoint in the OCT guidance group, as did 3 patients (3 cardiac deaths) in the angiographic guidance group (1.8% vs 2.6%; P = 0.67). Reinfarction was not observed in either group. At 1 year, the rates of predefined cardiocerebrovascular events were comparable between the groups (11.6% after OCT guidance vs 9.6% after angiographic guidance; P = 0.66). In patients with STEMI with early infarct artery patency, OCT guidance compared with angiographic guidance of reperfusion was associated with less stent implantation during primary percutaneous coronary intervention. These favorable results indicate the value of OCT imaging in optimizing the reperfusion strategy of patients with STEMI. (EROSION III: OCT- vs Angio-Based Reperfusion Strategy for STEMI; NCT03571269). |
Author | Wu, Yanqing Shi, Yongfeng Feng, Xue Li, Lulu Jia, Haibo Chen, Tao Li, Jianping Hou, Jingbo Dai, Jiannan Zhao, Lei Xu, Yishuo Yang, Yining Zhang, Dirui Liu, Bin Wang, Chunmei Weng, Ziqian He, Luping Xu, Yousheng Liu, Yin Sun, Zhiqi Yu, Bo Li, Lang Zhang, Xiling Mintz, Gary S |
Author_xml | – sequence: 1 givenname: Haibo surname: Jia fullname: Jia, Haibo organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China – sequence: 2 givenname: Jiannan surname: Dai fullname: Dai, Jiannan organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China – sequence: 3 givenname: Luping surname: He fullname: He, Luping organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China – sequence: 4 givenname: Yishuo surname: Xu fullname: Xu, Yishuo organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China – sequence: 5 givenname: Yongfeng surname: Shi fullname: Shi, Yongfeng organization: Department of Cardiology, The Second Hospital of Jilin University, Changchun, China – sequence: 6 givenname: Lei surname: Zhao fullname: Zhao, Lei organization: Department of Cardiology, The Second Hospital of Jilin University, Changchun, China – sequence: 7 givenname: Zhiqi surname: Sun fullname: Sun, Zhiqi organization: Department of Cardiology, Daqing Oilfield General Hospital, Daqing, China – sequence: 8 givenname: Yin surname: Liu fullname: Liu, Yin organization: Department of Cardiology, Tianjin Chest Hospital, Tianjin, China – sequence: 9 givenname: Ziqian surname: Weng fullname: Weng, Ziqian organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China – sequence: 10 givenname: Xue surname: Feng fullname: Feng, Xue organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China – sequence: 11 givenname: Dirui surname: Zhang fullname: Zhang, Dirui organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China – sequence: 12 givenname: Tao surname: Chen fullname: Chen, Tao organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China – sequence: 13 givenname: Xiling surname: Zhang fullname: Zhang, Xiling organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China – sequence: 14 givenname: Lulu surname: Li fullname: Li, Lulu organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China – sequence: 15 givenname: Yousheng surname: Xu fullname: Xu, Yousheng organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China – sequence: 16 givenname: Yanqing surname: Wu fullname: Wu, Yanqing organization: Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China – sequence: 17 givenname: Yining surname: Yang fullname: Yang, Yining organization: Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China; Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China – sequence: 18 givenname: Chunmei surname: Wang fullname: Wang, Chunmei organization: Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China – sequence: 19 givenname: Lang surname: Li fullname: Li, Lang organization: Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China – sequence: 20 givenname: Jianping surname: Li fullname: Li, Jianping organization: Department of Cardiology, Peking University First Hospital, Beijing, China – sequence: 21 givenname: Jingbo surname: Hou fullname: Hou, Jingbo organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China – sequence: 22 givenname: Bin surname: Liu fullname: Liu, Bin email: liubin3333@vip.sina.com organization: Department of Cardiology, The Second Hospital of Jilin University, Changchun, China. Electronic address: liubin3333@vip.sina.com – sequence: 23 givenname: Gary S surname: Mintz fullname: Mintz, Gary S organization: Cardiovascular Research Foundation, New York, New York, USA – sequence: 24 givenname: Bo surname: Yu fullname: Yu, Bo email: yubodr@163.com organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China. Electronic address: yubodr@163.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35367176$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkM1Og0AcxDemxn7oC3gwe_QC7i50AW8NwUrSimkxHsmy_Inb0AUXOPA2fZY-mSTWxNNMZia_w8zRRNcaELqnxKaE8qeDfZBK24wwZhNqs8C_QjPqe9zyOFlO_vkpmrftgRBOAo_doKmzdLhHPT5DZbRL9nHyhuM4fsYrvO2rTknQHRi8C1NclzgJU2vdqwIKvIMGTNm3qtZYabxPo22MP1X3hSNhquF8inUpjOzOp5UZCWPwLjrQcrhF16WoWri76AJ9vERp-GptknUcrjZWwyjtrFxKKqH0wCM0oNwH4ROfOoxR4Za5ywMgUrg-XeaFZJLIsWA-lyyXOXULQZwFevzlNqb-7qHtsqNqJVSV0FD3bcb4CHEJ52ycPlymfX6EImuMOgozZH_fOD_Ww2lf |
ContentType | Journal Article |
Copyright | Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.jcin.2022.01.298 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1876-7605 |
ExternalDocumentID | 35367176 |
Genre | Randomized Controlled Trial Multicenter Study Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 0SF 18M 1B1 1P~ 1~. 4.4 457 4G. 53G 5GY 5VS 7-5 8P~ AACTN AAEDW AAFTH AAIKJ AALRI AAOAW AAQFI AAXUO ABBQC ABFRF ABJNI ABMAC ABMZM ABVKL ACGFO ACGFS ADBBV ADEZE ADVLN AEFWE AEKER AEVXI AEXQZ AFCTW AFETI AFJKZ AFRHN AFTJW AGYEJ AITUG AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ BAWUL BLXMC CGR CS3 CUY CVF DIK EBS ECM EIF F5P FDB FEDTE FNPLU GBLVA HVGLF IXB J1W M41 MO0 N9A NPM O-L O9- OAUVE OA~ OK1 OL0 P-8 P-9 P2P PC. Q38 ROL SDF SEL SES SSZ T5K W8F Z5R 7X8 AAYWO AGCQF APXCP EFKBS |
ID | FETCH-LOGICAL-p211t-bcc1cef7e7019168ea80813221a4fb469e0ca4815bdc2c0c221286c2bcb14da03 |
ISSN | 1876-7605 |
IngestDate | Fri Sep 05 08:07:21 EDT 2025 Wed Feb 19 02:26:33 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | stent ST-segment elevation myocardial infarction optical coherence tomography reperfusion |
Language | English |
License | Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p211t-bcc1cef7e7019168ea80813221a4fb469e0ca4815bdc2c0c221286c2bcb14da03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
PMID | 35367176 |
PQID | 2646940662 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2646940662 pubmed_primary_35367176 |
PublicationCentury | 2000 |
PublicationDate | 2022-04-25 20220425 |
PublicationDateYYYYMMDD | 2022-04-25 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-25 day: 25 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | JACC. Cardiovascular interventions |
PublicationTitleAlternate | JACC Cardiovasc Interv |
PublicationYear | 2022 |
References | 35367171 - JACC Cardiovasc Interv. 2022 Apr 25;15(8):857-860 |
References_xml | – reference: 35367171 - JACC Cardiovasc Interv. 2022 Apr 25;15(8):857-860 |
SSID | ssj0060972 |
Score | 2.5765681 |
Snippet | The aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 846 |
SubjectTerms | Arteries Constriction, Pathologic - etiology Coronary Angiography - methods Humans Myocardial Infarction - diagnostic imaging Myocardial Infarction - etiology Myocardial Infarction - therapy Percutaneous Coronary Intervention - methods Prospective Studies Reperfusion ST Elevation Myocardial Infarction - diagnostic imaging ST Elevation Myocardial Infarction - etiology ST Elevation Myocardial Infarction - therapy Tomography, Optical Coherence - methods Treatment Outcome |
Title | EROSION III: A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35367176 https://www.proquest.com/docview/2646940662 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZB6UvY_d23YYG61NwkBxf9-aZbnGh6-hSyFuwZJm6MNsk9sP6a_Jb8st2dPHsdCtsezGJBA7o-3J0jvSdcxB676aqeYBj0SwkEKBQaqUkCy1XuDTw86mfqdYJ51-82ZVztnAXo9GPgWqpbdiE3_4xr-R_UIUxwFVmyf4Dsr9eCgPwGfCFJyAMz7_C-PTyQtrCcZIkOsNcpdNKvaVYjS_jufQEL-K59bktMiHzEGuxytu1kTd-mwMGYBaa67Eqc3wS2ycRScocuN_oL5EUfJqJr6l0r3dugc-iOJ5IzciOpHWgouz1iVqTO0sLVvWH40pJAFNl2XN0pjs_t3W3p8LYolU7RbG-bqvhMQVEuMSxdErzRGjTCnbX8j3i7thed8CxYGBIA30w-ZuB12cNN5MbXsjqtbYti67aupH1APH6u4J86k49iFfv1NrWu7eZeoAe2r6vbviTxcduE_dkVSOTY6XlgHd_8ADtd6-4PzhRTsr8MXpkogscaao8QSNRPkX750Y_8QzlhjEYGPMBR3jAFwx8wVWOe77gAV9wUWLFFyz5ghVfthvDle1G82S7MRx5jq4-nc7jmWU6bVi1TWljMc4pF7kvZHF-6gUilQ1ZwNbT1MmZ44WCyOr31GUZtznhMGEHHrcZZ9TJUjJ9gfbKqhSHCHsZEyT1fZKCcwh_dkYcEcguCKHDIBYXR-hdt1hLsGTyeiotRdWul-Cae6EjOxIcoZd6FZe1Lrmy7Jb61b0zx-igp91rtNesWvEG_MWGvVXI_gQFR2WI |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=EROSION+III%3A+A+Multicenter+RCT+of+OCT-Guided+Reperfusion+in+STEMI+With+Early%C2%A0Infarct%C2%A0Artery%C2%A0Patency&rft.jtitle=JACC.+Cardiovascular+interventions&rft.au=Jia%2C+Haibo&rft.au=Dai%2C+Jiannan&rft.au=He%2C+Luping&rft.au=Xu%2C+Yishuo&rft.date=2022-04-25&rft.eissn=1876-7605&rft.volume=15&rft.issue=8&rft.spage=846&rft_id=info:doi/10.1016%2Fj.jcin.2022.01.298&rft_id=info%3Apmid%2F35367176&rft.externalDocID=35367176 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1876-7605&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1876-7605&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1876-7605&client=summon |